Roivant Sciences (ROIV) Equity Ratio (2021 - 2025)
Historic Equity Ratio for Roivant Sciences (ROIV) over the last 5 years, with Q4 2025 value amounting to 0.95.
- Roivant Sciences' Equity Ratio fell 39.77% to 0.95 in Q4 2025 from the same period last year, while for Dec 2025 it was 0.95, marking a year-over-year decrease of 39.77%. This contributed to the annual value of 0.95 for FY2025, which is 685.73% up from last year.
- Per Roivant Sciences' latest filing, its Equity Ratio stood at 0.95 for Q4 2025, which was down 39.77% from 0.95 recorded in Q3 2025.
- In the past 5 years, Roivant Sciences' Equity Ratio registered a high of 0.96 during Q2 2025, and its lowest value of 0.62 during Q2 2023.
- Over the past 5 years, Roivant Sciences' median Equity Ratio value was 0.8 (recorded in 2021), while the average stood at 0.81.
- Its Equity Ratio has fluctuated over the past 5 years, first crashed by 1930.13% in 2022, then surged by 4533.17% in 2024.
- Over the past 5 years, Roivant Sciences' Equity Ratio (Quarter) stood at 0.8 in 2021, then decreased by 19.3% to 0.65 in 2022, then soared by 38.99% to 0.9 in 2023, then rose by 6.14% to 0.96 in 2024, then fell by 0.4% to 0.95 in 2025.
- Its Equity Ratio stands at 0.95 for Q4 2025, versus 0.95 for Q3 2025 and 0.96 for Q2 2025.